Qingjun Liu
P.R. China
Beijing, 100015, China
Beijing, 100015, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1.
Journal: Experimental and therapeutic medicine
Published: March 15, 2022
LncRNA PTAR activates the progression of bladder cancer by modulating miR-299-3p/CD164 axis.
Journal: Pathology, research and practice
Published: March 01, 2022
Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
Journal: Molecular cancer
Published: June 16, 2021
Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.
Journal: Molecular cancer
Published: June 12, 2021
MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma.
Journal: Oncology letters
Published: May 07, 2018
miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2.
Journal: Oncology letters
Published: March 13, 2018
Resveratrol-mediated apoptosis in renal cell carcinoma via the p53/AMP‑activated protein kinase/mammalian target of rapamycin autophagy signaling pathway.
Journal: Molecular medicine reports
Published: May 10, 2017
The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis.
Journal: Clinical and investigative medicine. Medecine clinique et experimentale
Published: April 26, 2017
mTOR activation is critical for betulin treatment in renal cell carcinoma cells.
Journal: Biochemical and biophysical research communications
Published: November 12, 2016
Nuclear expression and clinical significance of phosphohistidine phosphatase 1 in clear-cell renal cell carcinoma.
Journal: The Journal of international medical research
Published: November 17, 2014
Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.
Journal: Molecular cancer
Published: September 11, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026